Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
We have reported that tyrosine-phosphorylated forms of a cellular protein, FKBP52, inhibit the second-strand DNA synthesis of adeno-associated virus 2 (AAV), leading to inefficient transgene expression from recombinant AAV vectors. To further explore the role of FKBP52 in AAV-mediated transduction, we established murine embryo fibroblasts (MEFs) cultures from FKBP52 wild-type (WT), heterozygous (HE), and knockout (KO) mice. Conventional AAV vectors failed to transduce WT MEFs efficiently, and the transduction efficiency was not significantly increased in HE or KO MEFs. AAV vectors failed to traffic efficiently to the nucleus in these cells. Treatment with hydroxyurea (HU) increased the transduction efficiency of conventional AAV vectors by approximately 25-fold in WT MEFs, but only by approximately 4-fold in KO MEFs. The use of self-complementary AAV (scAAV) vectors, which bypass the requirement of viral second-strand DNA synthesis, revealed that HU treatment increased the transduction efficiency approximately 23-fold in WT MEFs, but only approximately 4-fold in KO MEFs, indicating that the lack of HU treatment-mediated increase in KO MEFs was not due to failure of AAV to undergo viral second-strand DNA synthesis. Following HU treatment, approximately 59% of AAV genomes were present in the nuclear fraction from WT MEFs, but only approximately 28% in KO MEFs, indicating that the pathway by which HU treatment mediates nuclear transport of AAV was impaired in KO MEFs. When KO MEFs were stably transfected with an FKBP52 expression plasmid, HU treatment-mediated increase in the transduction efficiency was restored in these cells, which correlated directly with improved intracellular trafficking. Intact AAV particles were also shown to interact with FKBP52 as well as with dynein, a known cellular protein involved in AAV trafficking. These studies suggest that FKBP52, being a cellular chaperone protein, facilitates intracellular trafficking of AAV, which has implications in the optimal use of recombinant AAV vectors in human gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferrari, F. K., Samulski, T., Shenk, T., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.3227-3234.1996 · Cited by 761 · cited 3×
“…rate-limiting step in AAVmediated transgene expression, and that a cellular protein, FKBP52, is a negative regulator of this step in the virus life cycle (Ferrari et al., 1996; Fisher et al., 1996; Mah et al., 1998; Qing et al., 1997, 1998, 2001, 2003; Zhong et al., 2004a, 2004b, 2004c, 2004d).”
BackgroundMcCarty, D., Monahan, P., & Samulski, R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301514 · Cited by 735 · cited 2×
“In order to determine whether the observed lack of increase in the transduction efficiency of AAV vectors in KO MEFs following HU treatment was related to viral second-strand DNA synthesis, we utilized double-stranded, self-complementary AAV (scAAV) vectors that obviate the need for viral second-strand DNA synthesis (…”
MethodWochnik, G. M., Rüegg, J., Abel, G. A., Schmidt, U., Holsboer, F., & Rein, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407498200 · Cited by 638
Bidirectional transport along microtubules
Welte, M. A. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.045 · Cited by 577 · cited 3×
“Trafficking on microtubules destined for either the cell center or the apical domains uses a cytoplasmic protein, dynein, since all endosome mobility ceased when dynein function was disrupted by the use of a mutant dynein heavy chain allele (Mallik and Gross, 2004; Murray and Wolkoff, 2003; Welte, 2004).”
BackgroundInfectious entry pathway of adeno-associated virus and adeno-associated virus vectors
Bartlett, J. S., Wilcher, R., & Samulski, R. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2777-2785.2000 · Cited by 532 · cited 1×
“Details of the intracellular pathway used by AAVare now beginning to be fully understood (Bartlett et al., 2000; Douar et al., 2001; Duan et al., 1999; Hansen et al., 2000, 2001a; Lux et al., 2005; Seisenberger et al., 2001; Warrington et al., 2004; Xiao et al., 2002).”
MethodHuman fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., & Srivastava, A. (1999) · Nature Medicine · doi:10.1038/4758 · Cited by 443 · cited 2×
“…(HSPG) and fibroblast growth factor receptor 1 (FGFR1), the cellular receptor and co-receptor, respectively, for AAV (Summerford and Samulski, 1998; Qing et al., 1999), were responsible for inefficient viral binding and entry into MEFs, we next performed fluorescence-activated cell sorting (FACS)…”
MethodSelf-citationRole of hsp90 and the hsp90-binding immunophilins in signalling protein movement
Pratt, W. B., Galigniana, M. D., Harrell, J. M., & DeFranco, D. B. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.02.004 · Cited by 285 · cited 2×
“…this complex has been shown to mediate cytoplasmic transport of a number of cellular and viral proteins to the nucleus (Czar et al., 1994a, 1994b; Denny et al., 2005; Perrot-Applanat et al., 1995; Pratt, 1998; Pratt et al., 1999, 2004; Pratt and Toft, 1997; Wochnik et al., 2005; Wu et al., 2004).”
BackgroundDouar, A.-M., Poulard, K., Stockholm, D., & Danos, O. (2001) · Journal of Virology · doi:10.1128/jvi.75.4.1824-1833.2001 · Cited by 282 · cited 1×
“Details of the intracellular pathway used by AAVare now beginning to be fully understood (Bartlett et al., 2000; Douar et al., 2001; Duan et al., 1999; Hansen et al., 2000, 2001a; Lux et al., 2005; Seisenberger et al., 2001; Warrington et al., 2004; Xiao et al., 2002).”
MethodWobus, C. E., Hügle-Dörr, B., Girod, A., Petersen, G., Hallek, M., & Kleinschmidt, J. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9281-9293.2000 · Cited by 273 · cited 1×
“Equivalent amounts of cytoplasm were immunoprecipitated with A20 antibodies, which specifically recognize only intact AAV particles with a defined three-dimensional structure (Wistuba et al., 1997; Wobus et al., 2000), and analyzed on Western blots.”
BackgroundGaligniana, M. D., Radanyi, C., Renoir, J.-M., Housley, P. R., & Pratt, W. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010809200 · Cited by 236 · cited 2×
“Additional studies have also documented that FKBP52 can bind either directly or via a linker protein with the cytoplasmic dynein; the PPIase domain fragment of FKBP52 interacts with dynein, and provides a link between the glucocorticoid receptor-HSP90 heterocomplex and cytoplasmic dynein for retrograde movement along…”
Background
Cited by
Zhong, L., Li, B., Mah, C. S., Govindasamy, L., Agbandje-McKenna, M., Cooper, M., Herzog, R. W., Zolotukhin, I., Warrington, K. H., Weigel-Van Aken, K. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802866105 · Cited by 558
Self-citationMechanisms of Hsp90 regulation
Prodromou, C. (2016) · Biochemical Journal · doi:10.1042/bcj20160005 · Cited by 311
Post-translational modifications of Hsp90 and their contributions to chaperone regulation
Mollapour, M., & Neckers, L. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.07.018 · Cited by 288
Mingozzi, F., Hasbrouck, N. C., Basner-Tschakarjan, E., Edmonson, S. A., Hui, D. J., Sabatino, D. E., Zhou, S., Wright, J. F., Jiang, H., Pierce, G. F., et al. (2007) · Blood · doi:10.1182/blood-2007-03-080093 · Cited by 254
Zhong, L., Li, B., Jayandharan, G., Mah, C. S., Govindasamy, L., Agbandje-McKenna, M., Herzog, R. W., Weigel-Van Aken, K. A., Hobbs, J. A., Zolotukhin, S., et al. (2008) · Virology · doi:10.1016/j.virol.2008.08.027 · Cited by 232
“Preparation of whole cell lysates (WCLs) and co-immunoprecipitations WCLs were prepared as described previously (Zhao et al., 2006; Zhong et al., 2004d; Zhong and Su, 2002), with the following modifications.”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Zhao, W., Zhong, L., Wu, J., Chen, L., Qing, K., Weigel-Kelley, K. A., Larsen, S. H., Shou, W., Warrington, K. H., & Srivastava, A.
- Venue
- Virology
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 353
- Issue
- 2
- Pages
- 283-293
- ISSN
- 0042-6822 (ISSN-L)
- OpenAlex
- W2019418234
- Cited by
- 69
- References
- 15
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors. https://app.cochat.ai/papers/10.1016/j.virol.2006.04.042
- The paper
- Zhao, W., Zhong, L., Wu, J., Chen, L., Qing, K., Weigel-Kelley, K. A., Larsen, S. H., Shou, W., Warrington, K. H., & Srivastava, A. (2006). Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors. Virology. https://doi.org/10.1016/j.virol.2006.04.042
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.